The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy

New Microbiologica

Volumn 38, Issue 2, 2015, Pages 137-147

  Sagnelli, Caterina ^a   Ciccozzi, Massimo ^b,c   Pisaturo, Mariantonietta ^a   Lo Presti, Alessandra ^b   Cella, Eleonora ^b   Coppola, Nicola ^a   Sagnelli, Evangelista ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Italian Institute of Health   (Italy)

^c University of Biomedical Campus   (Italy)

Author keywords

Acute hepatitis B; Epidemiology of acute hepatitis B; HBV genotypes and subgenotypes; HBV phylogenetic analysis

Indexed keywords

HEPATITIS B VIRUS;

CLASSIFICATION; GENETIC VARIABILITY; GENETICS; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; ISOLATION AND PURIFICATION; ITALY; PHYLOGENY; TRANSMISSION; VIROLOGY;

GENETIC VARIATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; ITALY; PHYLOGENY;

EID: 84930978992     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (113)

1. Amini-Bavil-Olyaee S., Sarrami-Forooshani R., Mahboudi F., Sabahi F., Adeli A., Noorinayer B., Azizi M., Reza Zali M. (2005). Genotype characterization and phylogenetic analysis of hepatitis B virus isolates from Iranian patients. J. Med. Virol. 75, 227-234.
2. Arauz-Ruiz P., Norder H., Robertson B.H., Magnius L.O. (2002). Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J. Gen. Virol. 83, 2059-2073.
3. Aye T.T., Uchida T., Becker S.O., Hirashima M., Shi-Kata T., Komine F., Moriyama M., Arakawa Y., Mima S., Mizokami M., Lau J.Y.N. (1994). Variations of hepatitis B virus precore/core gene sequence in acute and fulminant hepatitis B. Dig. Dis. Sci. 6, 1281-1287.
4. Bartenschlager R., Schaller H. (1988). The ami-no-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription. EMBO J. 7, 4185-4192.
5. Berk P.D., Popper H. (1978). Fulminant hepatic failure. Am. J. Gastroenterol. 69, 349-400.
6. Blumberg B.S. (2002). Hepatitis B-The hunt for a killer virus. Princeton: Princeton University Press.
7. Bon I., Ciccozzi M., Zehender G., Biagetti C., Verruc-Chi G., Lai A., Lo Presti A., Gibellini D., Re M.C. (2010). HIV-1 subtype C transmission network: the phylogenetic reconstruction strongly supports the epidemiological data. J. Clin. Virol. 48, 212-214.
8. Callegaro A., Svicher V., Alteri C, Lo Presti A., Va-Lenti D., Goglio A., Salemi M., Cella E., Perno C.F., Ciccozzi M., Maggiolo F. (2011). Epidemio-logical network analysis in HIV-1 B infected patients diagnosed in Italy between 2000 and 2008. Infect. Genet. Evol. 11, 624-632.
9. Carman W.F., Fagan E.A., Hadziyannis S., Karaylannis P., Tassopoulos N.C., Williams R., Thomas H.C. (1991). Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis. Hepatology. 14, 219-222.
10. Chen A., Ho Y., Tu Y., Shieh S., Cheng T. (1988). Hepatitis B virus-associated membranous glomerulo-nephropathy. J. Clin. Gastroenterol. 10, 243-246.
11. Chen H.L., Chang C.J. (2004). Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology. 39, 58-63.
12. Chlumsky J., Krtek V. (1982). HBsAg in ascitic fluid of patients with hepatic cirrhosis. Hepatogastro-enterology. 29, 106-107.
13. Chu C.J., Lok A.S.F. (2002). Clinical significance of hepatitis B genotypes. Hepatology. 35, 1274-1276.
14. Chu C.M., Yeh C.T., Chiu C.T., Sheen I.S., Liaw Y.F. (1996). Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which hepatitis B is endemic. J. Clin. Microbiol. 34, 1815-1818.
15. Ciccozzi M., Lai A., Ebranati E., Gabanelli E., Galli M., Mugosa B., Vratnica Z., Vujoevic D., Lauevic D., Ciotti M., Cella E., Lo Presti A., Zehender G. (2012). Phylogeographic reconstruction of HIV Type 1B in Montenegro and the Balkan Region. AIDS Res. Hum. Retroviruses. 28, 1280-1284.
16. Ciccozzi M., Zehender G., Cento V., Lo Presti A., Teo-Harov P., Pavlov I, Bogdanova V., Perno C.F., Ciotti M. (2011). Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users. J. Med. Virol. 83, 1565-1567.
17. Coppola N,. Sagnelli C., Pisaturo M., Minichini C., Messina V., Alessio L., Starace M., Signoriello G., Gentile.I, Filippini P., Sagnelli E. (2014). Clinical and Virological Characteristics Associated With Severe Acute Hepatitis B. Clin. Microbiol. Infect. 20: O991-7.
18. Coppola N., Loquercio G., Tonziello G., Azzaro R., Pi-Saturo M., Di Costanzo G., Starace M., Pasquale G., Cacciapuoti C., Petruzziello A. (2013). HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient. J. Clin. Virol. 58, 315-317.
19. Coppola N., Masiello A., Tonziello G., Pisapia R., Pi-Saturo M., Sagnelli C., Messina V., Iodice V., Sa-Gnelli E. (2010). Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. J. Viral. Hepat. 17, 493-500.
20. Coppola N., Potenza N., Pisaturo M., Mosca N., Ton-Ziello G., Signoriello G., Messina V., Sagnelli C., Russo A., Sagnelli E. (2013). Liver microRNA hsa-miR-125a-5p in HBV chronic infection: Correlation with HBV replication and disease progression. Plos One. 8, e65336.
21. Coppola N., Tonziello G., Colombatto P., Pisaturo M., Messina V., Moriconi F., Alessio L., Sagnelli C., Cavallone D., Brunetto M., Sagnelli E. (2013). Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B. J. Infect. 67, 322-328.
22. Dal Molin G., Poli A., Crocè L.S., D'agaro P., Biagi C., Comar M., Tiribelli C., Campello C. (2006). Hepatitis B virus genotypes, core promoter variants, and precore stop codon variants in patients infected chronically in North-Eastern Italy. J. Med. Virol. 78, 734-740.
23. De Maddalena C., Giambelli C., Tanzi E., Colzani D., Schiavini M., Milazzo L., Bernini F., Ebranati E., Cargnel A., Bruno R., Galli M., Zehender G. (2007). High level of genetic heterogeneity in S and P genes of genotype D hepatitis B virus. Virology. 365, 113-124.
24. De Oliveira T., Pybus O.G., Rambaut A., Salemi M., Cassol S., Ciccozzi M., Rezza G., Gattinara G.C., D'arrigo R,. Amicosante M., Perrin L., Colizzi V., Perno.Cf., Benghazi Study Group. (2006). Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak. Nature. 444, 836-837.
25. Deterding K., Constantinescu I., Nedelcu F.D., Gervain J., Nemecek V., Srtunecky O., Vince A., Grgurevic I., Bielawski K.P., Zalewska M., Bock T., Ambrozaitis A., Stanczak J., Takács M., Ch-Ulanov V., Slusarczyk J., Drazd'áková M., Wie-Gand J., Cornberg M., Manns M.P., Wedemeyer H. (2008). Prevalence of HBV genotypes in Central and Eastern Europe. J. Med. Virol. 80, 1707-1711.
26. Dienstag J.L. (1981). Hepatitis B as an immune complex disease. Semin. Liver. Dis. 1, 45-57.
27. Drummond A., Pybus O.G., Rambaut A. (2003). Inference of viral evolutionary rates from molecular sequences. Adv. Rasitol. 54, 331-58.
28. Ehata T., Omata M., Chuang W., Yokosuka O., Ito Y., Hosoda K., Ohto M. (1993). Mutations in the core nucleotide sequence of HBV virus correlate with fulminant and severe hepatitis. J. Clin. Invest. 91, 1206-1213.
29. Felsenstein J. Inferring Phylogenies. (2004). Sinauer Associates, Sunderland, MA
30. Ferraro D., Urone N., Pizzillo P., Gussio M., Magliocco S., Cacopar-Do B., Craxì A., Di Marco V., Di Stefano R. (2012). Phylogenetic analysis of isolates from new cases of HBV infection in Southern Italy. Infect. Genet. Evol. 12, 1591-1596.
31. Fitch W.M., Margoliash E. (1967). Construction of phylogenetic trees. Science. 155, 279-284.
32. Flink H.J., Van Zonneveld M., Hansen B.E., De Man R.A., Schalm S.W., Janssen H.L., Hbv 99-01 Study Group. (2006). Treatment with Peg-interferon al-pha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype. Am. J. Gastroenterol. 101, 297-303.
33. Garfein R.S., Bower W.A., Loney C.M., Hutin Y.J., Xia G.L., Jawanda J., Groom A.V., Nainan O.V., Murphy J.S., Bell B.P. (2004). Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepa-tology. 40, 865-873.
34. Gianotti F. (1966). Viral anicteric hepatitis in infantile papular acrodermatitis. Epatologia. 12, 171-191.
35. Hasegawa K, Huang J., Wands J.R., Obata H., Liang J. (1991). Association of hepatitis B viral precore mutations with fulminant hepatitis B in Japan. Virology. 185, 460-463.
36. Hayashi K., Katano Y., Takeda Y., Honda T., Ishigami M., Itoh A., Hirooka Y., Nakano I., Yoshioka K., Toyoda H., Kumada T., Goto H. (2008). Association of hepatitis B virus subgenotypes and basal core promoter/precore region variants with the clinical features of patients with acute hepatitis. J. Gastroenterol. 43, 558-564.
37. He B., Fan Q., Yang F., Hu T., Qiu W., Feng Y., Li Z., Li Y., Zhang F., Guo H., Zou X., Tu C. (2013). Hepatitis virus in long-fingered bats, Myanmar. Emerg. Infect. Dis. 19, 638-640.
38. Hollinger F.B., Liang T.J. (2001). Hepatitis B Virus. In: Knipe Dm, Howley Pm. Fields Virology. Philadelphia: Lippincott Williams and Wilkins, 2971-3036.
39. http://www.iss.it
40. Imamura T., Yokosuka O., Kurihara T., Kanda T., Fu-Kai K., Imazeki F., Saisho H. (2003). Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan. Gut. 52, 1630-1637.
41. Johnson R.J., Couser W.G. (1990). Hepatitis B infection and renal disease: clinical, immunopathoge-netic, and therapeutic considerations. Kidney Int. 37, 663-676.
42. Kaneko M., Uchida T., Moriyama M., Arakawa Y., Shi-Kata T., Gotoh K., Mima S. (1995). Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B. J. Med. Virol. 47, 204-208.
43. Kao J.H. (2002). Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J. Gas-troenterol. Hepatol. 17, 643-650.
44. Karayiannis P., Novick D.M., Lok A.S.F., Fowler M.J.F., Monjardino J., Thomas H.C. (1985). Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen. Br. Med. J. 290, 1853-1855.
45. Kidd-Ljunggren K., Miyakawa Y., Kidd A.H. (2002). Genetic variability in hepatitis B viruses. J. Gen. Virol. 83, 1267-1280.
46. Kojima M., Shimizu M., Tsuchimochi T., Koyasu M., Tanaka S., Iizukah, Tanaka T., Okamoto H., Tsuda F., Miyakawa Y., Mayumi M. (1991). Posttransfusion fulminant hepatitis B associated with precore-de-fective HBV mutants. Vox. Sang. 60, 34-39.
47. Kosaka Y., Takase K., Kojima M., Shimizu M., Inoue K., Yoshiba M., Tanaka S., Akahane Y., Okamoto H., Tsuda F., Miyakawa Y., Mayumi M. (1991). Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology. 100, 1087-1094.
48. Kumar M., Satapathy S., Monga R., Das K., Hissar S., Pande C., Sharma B.C., Sarin S.K. (2007). A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology. 45, 96-101.
49. Kusakabe A., Tanaka Y., Mochida S., Nakayama N., In-Oue K., Sata M., Isoda N., Kang J.H., Sumino Y., Yatsuhashi H., Takikawa Y., Kaneko S., Yamada G., Karino Y., Tanaka E., Kato J., Sakaida I., Izumi N., Sugauchi F., Nojiri S., Joh T., Miyakawa Y., Mizoka-Mi M. (2009). Case-control study for the identification of virological factors associated with fulminant hepatitis B. Hepatol. Res. 39, 648-656.
50. Lanini S., Garbuglia A.R., Puro V., Solmone M,. Martini L., Arcese W., Nanni Costa A., Borgia P., Piselli P., Capobionchi M.R., Ippolito G. (2012). Hospital cluster of HBV infection: molecular evidence of patient-to-patient transmission through lancing device. Plos One. 7, e33122.
51. Lavanchy D. (2004). Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral. Hepatol. 11, 97-107.
52. Lavanchy D. (2005). Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J. Clin. Virol. 34 (Suppl. 1), S1-3.
53. Lemey P., Salemi M., Vandamme A.M. (2009). A practical approach to phylogenetic analysis and hypothesis testing. The Phylogenetic Handbook NY Cambridge University Press. 430.
54. Liang T.J., Hasegawa K., Rimon N., Wands J., Ben-Po-Rath E. (1991). A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N. Engl. J. Med. 324, 1705-1709.
55. Liaw Y.F, Chu C.M. (2009). Hepatitis B virus infection. Lancet. 14; 373, 582-592.
56. Lisker-Melman M., Webb D., Di Bisceglie A.M., Kas-Sianides C., Martin P., Rustgi V., Waggoner J.G., Park Y,. Hoofnagle J.H. (1989). Glomerulonephri-tis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon. Ann. Intern. Med. 111, 479-483.
57. Lyra A.C., Pinho J.R., Mello I.M., De M., Malta F., Gomes M.M., Di Bisceglie A.M., Lyra L.G., Carril-Ho F.J., Da Silva L.C. (2005). Distribution of hepatitis B virus (HBV) genotypes among patients with acute viral hepatitis. J. Clin. Gastroenterol. 39, 81-82.
58. Mahtab M., Rahman S., Khan M., Karim F. (2008). Hepatitis B virus genotypes: an overview. Hepato-biliary. Pancreat. Dis. Int. 7, 457-464.
59. Miyakawa Y., Mizokami M. (2003). Classifying hepatitis B virus genotypes. Intervirology. 46, 329-338.
60. Nassal M. (1999). Hepatitis B virus replication: novel roles for virus host interactions. Intervirology 42, 100-116.
61. Naumann H., Schaefer S., Yoshida C.F., Gaspar A.M., Repp R., Gerlich W.H. (1993). Identification of a new hepatitis B virus (HBV) genotype from Brazil that expresses HBV surface antigen subtype adw4. J. Gen. Virol. 74, 1627-1632.
62. Norder H. (1995). Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. In-tervirology. 38, 24-34.
63. Norder H., Couroucé A.M., Coursaget P., Echevarria J.M., Lee S.D., Mushahwar I.K., Robertson B.H., Locarnini S., Magnius L.O. (2004). Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology. 47, 289-309.
64. Norder H., Couroucé A.M., Magnius L.O. (1994). Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology. 198, 489-503.
65. Okamoto H., Tsuda F., Sakugawa H., Sastrosoewignjo R.I., Imai M., Miyakawa Y., Mayumi M. (1988). Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J. Gen. Virol. 69, 2575-2583.
66. Olinger C.M., Jutavijittum P., Hubschen J.M., You-Sukh A., Samountry B., Thammavong T., Toriyama K., Muller C.P. (2008). Possible new hepatitis B virus genotype, southeast Asia. Emerg. Infect. Dis. 14, 1777-1780.
67. Omata M., Ehata T., Yokosuka O., Hosoda K., Ohto M. (1991). Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N. Engl. J. Med. 324, 1699-1704.
68. Ott J.J., Stevens G.A., Groeger J., Wiersma S.T. (2012). Global epidemiology of hepatitis B virus infection: new estimates of age-specific HB-sAg seroprevalence and endemicity. Vaccine. 30, 2212-2219.
69. Ozasa A., Tanaka Y., Orito E., Sugiyama M., Kang J.H., Hige S., Kuramitsu T., Suzuki K., Tanaka E., Oka-Da S., Tokita H., Asahina Y., Inoue K., Kakumu S, Okanoue T., Murawaki Y., Hino K., Onji M., Yat-Suhashi H., Sakugawa H., Miyakawa Y., Ueda R., Mizokami M. (2006). Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepa-tology. 44, 326-334.
70. Panessa C., Hill W.D., Giles E., Yu A., Harvard S., Butt G., Andonov A., Krajden M., Osiowy C. (2009). Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia. J. Viral. Hepat. 16, 64-73.
71. Petrosillo N., Ippolito G., Solforosi L., Varaldo P.E., Clementi M., Manzin A. (2000). Molecular epidemiology of an outbreak of fulminant hepatitis B. J. Clin. Microbio.l 38, 2975-2981.
72. Piasecki T., Harkins G.W., Chrzastek K., Julian L., Martin D.P., Varsani A. (2013). Avihepadnavirus diversity in parrots is comparable to that found amongst all other avian species. Virology. 438, 98-105.
73. Piccinino F., Manzillo G., Sagnelli E., Balestrieri G.G., Maio G., Pasquale G., Felaco F.M. (1978). The significance of the Australia antigen (HBsAg) persistent healthy carrier "status": a long-term follow-up study of 34 cases. Acta Hepatogastroen-terol. (Stuttg). 25, 171-178.
74. Pol D. (2004). Empirical problems of the hierarchical likelihood ratio test for model selection. Syst. Biol. 53, 949-962.
75. Prince A.M. (1968). Relation of Australia and SH antigens. Lancet. 2, 462-463.
76. Rantala M., Van De Laar M.J. (2008). Surveillance and epidemiology of hepatitis B and C in Europe-a review. Euro. Surveill. 13, pii 18880.
77. Riberio N.R., Campos G.S., Angelo A.L., Braga E.L., Santana N., Gomes M.M., Pinho J.R., De Carvalho W.A., Lyra L.G., Lyra A.C. (2006). Distribution of hepatitis B virus genotypes among patients with chronic infection. Liver. Int. 26, 636-642.
78. Romanò L., Paladini S., Tagliacarne C., Zappa A., Za-Netti A.R. (2009) The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination. Vaccine. 26, 3439-3442.
79. Sagnelli C., Ciccozzi M., Pisaturo M., Zehender G., Lo Presti A., Alessio L., Starace M, Lovero D., Sagnelli E., Coppola N. (2014). Molecular epidemiology of hepatitis B virus genotypes circulating in acute hepatitis B patients in the Campania region. J. Med. Virol. 86: 1683-1693.
80. Sagnelli E., Coppola N., Messina V., Di Caprio D., Marrocco C., Marotta A., Onofrio M., Scolastico C., Filippini P. (2002). HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course. Hepatology. 36, 1285-1291.
81. Sagnelli E., Coppola N., Pisaturo M., Masiello A., Tonziello G., Sagnelli C., Messina V., Filippini P. (2009). HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV. Hepatology. 49, 1090-1097.
82. Sagnelli E., Sagnelli C., Pisaturo M., Macera M., Coppola N. (2014). Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy. World J. Gastroenterol. 20, 7635-7643.
83. Saitou N., Nei M. (1987). The neighbor-joining method: a new method for reconstructing phylogenet-ic trees. Mol. Bio.l Evol. 4, 406-425.
84. Sakamoto T., Tanaka Y., Orito E., Co J., Clavio J, Sugauchi F., Ito K., Ozasa A., Quino A., Ueda R., Sollano J., Mizokami M. (2006). Novel subtypes (subgenotypes) of hepatitis B virus genotypes B and C among chronic liver disease patients in the Philippines. J. Gen. Virol. 87, 1873-1882.
85. Salemi M., Goodenow M.M., Montieri S., De Oliveira T., Santoro M.M., Beshkov D., Alexiev I., Elenkov I., Elenkov I., Yakimova T., Varleva T, Rezza G., Ciccozzi M. (2008). The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries. AIDS Res. Hum. Retro-vir. 24, 771-779.
86. Sato S., Suzuki K., Akahane Y., Akamatsu K., Akiyama K., Yunomura K., Tsuda F., Tanaka T., Okamoto H., Miyakawa Y., Mayumi M. (1995). Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann. Intern. Med. 122, 241-248.
87. Schaefer S. (2007). Hepatitis B virus genotypes in Europe. Hepatol. Res. 37, S20-S26.
88. Schaefer S. (2007). Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J. Gastroenter-ol 13, 14-21.
89. Sloan R.D., Strang A.L., Ramsay M.E., Teo C.G. (2009). Genotyping of acute HBV isolates from England, 1997-2001. J. Clin. Virol. 44, 157-160.
90. Stroffolini T., Coppola R., Carvelli C., D'angelo T., De Masi S., Maffei C., Marzolini F., Ragni P., Coti-Chini R., Zotti C., Mele A. (2008). Increasing hepatitis B vaccination coverage among healthcare workers in Italy 10 years apart. Dig. Liver. Dis. 40, 275-277.
91. Stuyver L., De Gendt S., Van Geyt C., Zoulim F., Fried M., Schinazi R.F., Rossau R. (2000). A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J. Gen. Virol. 81, 6-74.
92. Sumi H., Yokosuka O., Seki N., Arai M., Imazeki F., Kurihara T., Kanda T, Fukai K., Kato M., Saisho H. (2003). Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology. 37, 19-26.
93. Summers J., Mason W.S. (1982). Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell. 29, 403-415.
94. Svicher V., Gori C., Trignetti M., Visca M., Micheli V., Bernassola M., Salpini R., Gubertini G., Longo R., Niero F., Ceccherini-Silberstein F., De Sanctis G.M., Spanò A., Cappiello G., Perno C.F. (2009). The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes. J. Hepatol. 50, 461-470.
95. Takeda Y., Katano Y., Hayashi K., Honda T., Yokozaki S., Nakano I., Yano M., Yoshioka K., Toyoda H., Kumada T., Goto H. (2006). Difference of HBV genotype distribution between acute hepatitis and chronic hepatitis in Japan. Infection. 34, 201-207.
96. Tatematsu K., Tanaka Y., Kurbanov F., Sugauchi F., Mano S., Maeshiro T., Nakayoshi T., Wakuta M., Miyakawa Y., Mizokami M. (2009). A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J. Virol. 83, 10538-10547.
97. Tran T.T., Trinh T.N., Abe K. (2008) New complex recombinant genotype of hepatitis B virus identified in Vietnam. J. Virol. 82, 5657-5663.
98. Trepo C., Guillevin L. (2001). Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J. Autoimmun. 16, 269-274.
99. Tseng T.C., Kao J.H. (2008). HBV genotype and clinical outcome of chronic hepatitis B: facts and puzzles. Gastroenterology. 134, 1272-1273.
100. Van Houdt R., Bruisten Sm, Koedijk Fd, Dukers N.H., Op De Coul E.L., Mostert M.C., Niesters Hg, Richardus J.H., De Man R.A., Van Doornum G.J., Van Den Hoek J.A., Coutinho R.A., Van De Laar M.J., Boot H.J. (2007). Molecular epidemiology of acute hepatitis B in the Netherlands in 2004: nationwide survey. J. Med. Virol. 79, 895-901.
101. Venkateshan V.S., Lieberman K., Kim D.U., Thung S.N., Dikman S,. D'agati V., Susin M., Valderra-Ma E., Gauthier B., Prakash A. (1990). Hepatitis B-associated glomerulonephritis: pathology, pathogenesis, and clinical course. Medicine. 69, 200-216.
102. Villarejos V.M., Visona K.A., Gutiérrez A., Rodrìguez A. (1974). Role of saliva, urine and feces in the transmission of type B hepatitis. N. Engl. J. Med. 1375-1378.
103. Wai C.T., Fontana R.J., Polson J., Hussain M., Shakil A.O., Han S.H., Davern T.J., Lee W.M., Lok A.S., Us Acute Liver Failure Study Group. (2005). Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States. J. Viral. Hepatol. 12, 192-198.
104. Westland C., Delaney W. 4Th, Yang H., Chen S.S., Marcellin P., Hadziyannis S., Gish R., Fry J., Bros-Gart C., Gibbs C., Miller M., Xiong S. (2003). Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipiv-oxil. Gastroenterology. 125, 107-116.
105. Yang Z., Rannala B. (1997). Bayesian phylogenetic inference using DNA sequences: a Markov chain Monte Carlo method. Mol. Biol. Evol. 14, 717-724.
106. Yao G.B. (1996). Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut. 38 (Suppl. 2), S39-42.
107. Yoffe B., Burns D.K., Bhatt H.S., Combes B. (1990). Extrahepatic B virus DNA sequences in patients with acute hepatitis B infection. Hepatology. 12, 187-192.
108. Yu H., Yuan Q., Ge S.X., Wang H.Y., Zhang Y.L., Chen Q.R., Zhang J., Chen Pj, Xia N.S. (2010). Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "i". Plos One. 5, e9297.
109. Yuen M-F., Shinkai N., Poon R.T., But D.Y., Fong D.Y., Fung J., Wong D.K., Yuen J.C., Mizokami M., Lai C.L. (2008). Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations or enhancer II/core promoter/pre-core regions and HBV-DNA levels. Gut. 57, 98-102.
110. Zehender G., De Maddalena C., Giambelli C., Milaz-Zo L., Schiavini M., Bruno R., Tanzi E., Galli M. (2008). Different evolutionary rates and epidemic growth of hepatitis B virus genotypes A and D. Virology. 380, 84-90.
111. Zehender G., Ebranati E., Gabanelli E., Sorrentino C., Lo Presti A., Tanzi E., Ciccozzi M., Galli M. (2014). Enigmatic origin of hepatitis B virus: An ancient travelling companion or a recent encounter? World J. Gastroenterol. 20, 7622-7634.
112. Zehender G., Ebranati E., Lai A., Santoro M.M., Alte-Ri C., Giuliani M., Palamara G., Perno C.F., Galli M., Lo Presti A., Ciccozzi M. (2010). Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, Italy. J Acquir. Immune. Defic. Syndr. 55, 156-160.
113. Zehender G., Shkjezi R., Ebranati E., Gabanelli E., Abazaj Z., Tanzi E., Kraja D., Bino S., Ciccozzi M., Galli M. (2012). Reconstruction of the epidemic history of hepatitis B virus genotype D in Albania. Infect. Genet. Evol. 12, 291-298.